airmid healthgroup BLOG

latest news and science updates from airmid healthgroup

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Tags
    Tags Displays a list of tags that have been used in the blog.

Silicon Docks – Ireland’s version of Silicon Valley

Posted by on in airmid healthgroup BLOG
  • Font size: Larger Smaller
  • Hits: 3571
  • Subscribe to this entry
  • Print

grand-canal-quayThe neighbourhood bordering the Grand Canal Docks in Dublin where airmid healthgroup's facilities are based has become a hub of start ups, entrepreneurs, tech giants, and innovation, leading to it becoming known as “Silicon Docks”.  Following in the footsteps of Google & Facebook, a myriad of leading international companies and investors are being attracted to the area.

 

Figures from Ireland’s Industrial Development Authority (IDA) show that in 2012, 140 foreign companies either expanded or launched in Ireland. One of the principal reasons that companies invest in Ireland is access to skilled labour. In a recent Economist Intelligence Unit (EIU) report commissioned by Citibank, Dublin ranked first for “human capital” in their Global City Competitiveness Index. 

Ireland has a rich history of achievements in science and technology and continues to invest in world class research institutes and universities. CRANN, a nanoscience institute and neighbour to airmid healthgroup on Trinity College’s Enterprise Campus, recently secured a lead role in the Future and Emerging Technologies (FET) Graphene Flagship project. The EU Commission has committed €1 billion to this project, the largest ever research project funded in the history of the European Union.

Another key selling point for Ireland is her favourable tax system which actively encourages not only inward investment, but also research and development.   Ireland provides one of the leading jurisdictions in the world to create IP through research and development. Companies based in Ireland have the ability to reduce their effective corporation tax to as low as 2.5% on income arising from the management, development and exploitation of their IP. This can be achieved by taking advantage of Ireland's low corporation tax of 12.5%, generous R&D tax credits and competitive onshore IP regime.

airmid healthgroup aims to assist companies to source and develop IP through diverse channels such as open innovation, university collaboration, joint venture or direct acquisition.We can offer access to leading edge technologies being developed in Universities and Research Institutes, together with access to world class facilities to undertake contract research where ideas can be fostered from development prototypes into market ready products. 

In addition, funding opportunities for research projects are available from various sources including Enterprise Ireland, and the upcoming framework programme for research and innovation in Europe, Horizon 2020.This is due to replace Framework Programme Seven (FP7) in 2014.Researchers and companies in Ireland are expected to have received around €600 million in funding awards under FP7 by the end of 2013.

airmid healthgroup continues to thrive by capitalising on this favourable environment for innovation. It has assembled a highly skilled team with expertise in allergy, microbiology, aerobiology and molecular biology.It has also built up world class facilities to study the effect that products and services can have on indoor air quality.  It is, therefore, no surprise that in the past 12 months, airmid healthgroup has worked with 2 out of the Top 10 Most Innovative companies in the world as voted in a recent survey by a leading management consultancy, Booz & Company. It has also engaged with the research and development departments of 8 Fortune & Global 500 companies. The World Health Organisation has ranked indoor air pollution as a high priority health risk and ranks it 5th in the list of causes of ill health.airmid healthgroup aims to be at the forefront of tackling this issue and providing solutions that will contribute to healthier indoor environments.

Contact Graeme Tarbox if you have any questions on the issues raised in this article and how we can add value to your company: gtarbox@airmidhealthgroup.com

About airmid healthgroup
We help our clients across a number of sectors improve, add value and differentiate their customer offerings through a focus on bio-medical data, health impact claims and air quality. We have a uniquely integrated facility which combines molecular biology and state-of-the-art air sampling in a highly developed environmental test chamber, where we can follow nominated allergens, viruses, bacteria, molds or other ultra-fine particles. As a world leading biomedical and aerobiology research facility our clients describe us as a specialised extension to their research capabilities, we capture, store and manage your data and most importantly convert it into value.

Further reading
Why Ireland? A highly attractive location for Research & Development
Why Dublin's Tech Scene Is Booming
Irish scientists to play key role in giant €1 billion project